Next generation minimally invasive photodynamic therapy for treating COVID-19
Lead Participant:
VIVISCO LIMITED
Abstract
We are developing the next generation of medical devices which activate light-sensitive drugs. We will use these medical devices to enable light-activated drugs to be used as a treatment of COVID-19\.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| VIVISCO LIMITED | £49,491 | £ 49,491 |
People |
ORCID iD |
| Alastair Kirby (Project Manager) |